Policy2 sources
White House Withdraws Nomination of Heidi Overton to Be F.D.A. Commissioner
NYT > Health · By Christina Jewett ·
The Brief · written from 2 sources
- The White House withdrew its nomination of Heidi Overton, MD, PhD, to lead the FDA on November 17, 2026.
- The withdrawal came as indications grew that Overton lacked the votes needed for Senate confirmation.
- The Senate health committee had been scheduled to vote on her nomination on Wednesday morning.
Why it matters
The FDA is without a nominee for commissioner, so the agency's leadership and direction remain unsettled. Science and medical readers should watch who is nominated next and how the Senate responds.
Who’s affected
- readers following FDA leadership and US health policy
- physicians and researchers who depend on FDA regulatory decisions
- #fda
- #fda commissioner
- #senate confirmation
- #white house
- #health policy
The Senate health committee was scheduled to vote on her nomination Wednesday morning, but it became increasingly clear that she did not have enough support.
Timeline
Full coverage · 2 sources
- 2h ago ↗
NYT > Health
White House Withdraws Nomination of Heidi Overton to Be F.D.A. Commissioner
- 3h ago ↗
MedPageToday.com - medical news for physicians
White House Yanks Pick for FDA Chief